Literature DB >> 27409069

Increased bone turnover, osteoporosis, progressive tibial bowing, fractures, and scoliosis in a patient with a final-exon SATB2 frameshift mutation.

Philip M Boone1, Yiu Man Chan2, Jill V Hunter3, Louis E Pottkotter3, Nelson A Davino4, Yaping Yang1,5, Joke Beuten1,5, Carlos A Bacino6,7,8.   

Abstract

Haploinsufficiency of SATB2 causes cleft palate, intellectual disability with deficient speech, facial and dental abnormalities, and other variable features known collectively as SATB2-associated syndrome. This phenotype was accompanied by osteoporosis, fractures, and tibial bowing in two previously reported adult patients; each possessed SATB2 mutations either predicted or demonstrated to escape nonsense-mediated decay, suggesting that the additional bone defects result from a dominant negative effect and/or age-dependent penetrance. These hypotheses remain to be confirmed, as do the specific downstream defects causing bone abnormalities. We report a SATB2 mutation (c.2018dupA; p.(H673fs)) in a 15-year-old patient whose SATB2-associated syndrome phenotype is accompanied by osteoporosis, fractures, progressive tibial bowing, and scoliosis. As this homeodomain-disrupting and predicted truncating mutation resides within the final exon of SATB2, escape from nonsense-mediated decay is likely. Thus, we provide further evidence of bone phenotypes beyond those typically associated with SATB2-associated syndrome in individuals with potential dominant-negative SATB2 alleles, as well as evidence for age-dependence of bone features. Elevations in alkaline phosphatase, urinary N-telopeptide/creatinine ratio, and osteocalcin in the patient indicate increased bone turnover. We propose surveillance and treatment with osteoclast inhibitors to prevent fractures and to slow progressive bone deformities.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Glass syndrome; SATB2; bone remodeling; osteoclastic activity; tibial bowing

Mesh:

Substances:

Year:  2016        PMID: 27409069     DOI: 10.1002/ajmg.a.37847

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Satb2 regulates proliferation and nuclear integrity of pre-osteoblasts.

Authors:  Todd Dowrey; Evelyn E Schwager; Julieann Duong; Fjodor Merkuri; Yuri A Zarate; Jennifer L Fish
Journal:  Bone       Date:  2019-07-17       Impact factor: 4.398

2.  Individuals with SATB2-associated syndrome with and without autism have a recognizable metabolic profile and distinctive cellular energy metabolism alterations.

Authors:  Yuri A Zarate; Jenny-Li Örsell; Katherine Bosanko; Sujata Srikanth; Lauren Cascio; Rini Pauly; Luigi Boccuto
Journal:  Metab Brain Dis       Date:  2021-03-04       Impact factor: 3.584

3.  A novel mutation of SATB2 inhibits odontogenesis of human dental pulp stem cells through Wnt/β-catenin signaling pathway.

Authors:  Tianyi Xin; Qian Li; Rushui Bai; Ting Zhang; Yanheng Zhou; Yuehua Zhang; Bing Han; Ruili Yang
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 6.832

4.  SATB2-associated syndrome: characterization of skeletal features and of bone fragility in a prospective cohort of 19 patients.

Authors:  M Mouillé; M Rio; S Breton; M L Piketty; A Afenjar; J Amiel; Y Capri; A Goldenberg; C Francannet; C Michot; C Mignot; L Perrin; C Quelin; J Van Gils; G Barcia; V Pingault; G Maruani; E Koumakis; V Cormier-Daire
Journal:  Orphanet J Rare Dis       Date:  2022-03-03       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.